Advertisement

Topics

Approval of funding for Juno Pemetrexed for the treatment of mesothelioma and NSCLC in NZ

07:43 EDT 18 Aug 2017 | thePharmaLetter

New Zealand’s Pharmaceutical Management Agency PHARMAC today announced the approval of a proposal to…

Original Article: Approval of funding for Juno Pemetrexed for the treatment of mesothelioma and NSCLC in NZ

NEXT ARTICLE

More From BioPortfolio on "Approval of funding for Juno Pemetrexed for the treatment of mesothelioma and NSCLC in NZ"

Advertisement
Quick Search
Advertisement
Advertisement